Run Antibiotic Time-Out at 72 Hours Inspection — Free

Review Context

Antibiotic therapy reviewed at approximately 72 hours critical (required)

Verify the review occurred near the 72-hour mark after antibiotic initiation.

Yes No N/A

Indication for antibiotic therapy documented critical (required)

The clinical reason for treatment should be clearly documented.

Yes No N/A

Current antibiotic regimen identified

Confirm the active agent(s), dose, route, and frequency are available for review.

Yes No N/A

Relevant cultures and diagnostic results reviewed critical (required)

Review microbiology, imaging, and other diagnostic data that may affect therapy.

Yes No N/A

Culture and Susceptibility Review

Culture results available

Determine whether culture data are available at the time of review.

Yes No N/A

Organism identified and susceptibilities reviewed when available critical (required)

If cultures are positive, confirm the organism and susceptibility profile were reviewed.

Yes No N/A

Therapy aligned with culture and susceptibility results critical (required)

Verify the regimen matches the identified pathogen and susceptibility data.

Yes No N/A

No growth or contaminant results considered appropriately

Assess whether negative or contaminant results were used to guide therapy decisions.

Yes No N/A

Additional diagnostic data support ongoing infection

Clinical findings, labs, and imaging should support continued treatment if antibiotics are maintained.

Yes No N/A

Necessity and De-escalation

Ongoing need for antibiotics reassessed critical (required)

Confirm the team reassessed whether antimicrobial therapy remains indicated.

Yes No N/A

Opportunity to de-escalate identified

Determine whether broad-spectrum therapy can be narrowed based on current information.

Yes No N/A

Antibiotics discontinued when infection unlikely or ruled out critical (required)

If evidence does not support infection, therapy should be stopped or clearly justified.

Yes No N/A

Planned duration of therapy documented

A target stop date or total duration should be documented when therapy continues.

Yes No N/A

Stewardship recommendation communicated to care team

Confirm recommendations were shared with the prescribing or primary team.

Yes No N/A

IV-to-PO Conversion Assessment

Patient clinically stable for oral therapy critical (required)

Assess hemodynamic stability, improving symptoms, and overall clinical trajectory.

Yes No N/A

Able to tolerate oral intake critical (required)

Confirm the patient can swallow and absorb oral medications.

Yes No N/A

Appropriate oral antibiotic option available

Verify an oral agent with suitable spectrum and bioavailability is available.

Yes No N/A

IV-to-PO conversion recommended

Indicate whether conversion should be made based on the review.

Yes No N/A

Documentation and Follow-Up

Assessment and recommendation documented in chart critical (required)

The 72-hour review should be visible in the medical record.

Yes No N/A

Follow-up plan documented

Include next review timing, lab follow-up, or culture follow-up as needed.

Yes No N/A

Inspector signature critical (required)

Signature of the reviewer completing the audit.

Get your results

Enter your email — we'll send you a PDF of your filled-out template. We won't sign you up to anything; you can opt in to the trial from the email if you want.

Email (required)

Your name (optional)

Run: Antibiotic Time-Out at 72 Hours Inspection

Review Context

Culture and Susceptibility Review

Necessity and De-escalation

IV-to-PO Conversion Assessment

Documentation and Follow-Up

Get your results